Pregunta 1:
opción todas
Shoback D, Sellmeyer D and Bikle D. 2007 Glucocorticoid-induced osteoporosis en: Gardner D and Shoback D,ed.: Greenspan`s Basic &Clinical Endocrinology 8th edition. New York. Mc Graw-Hill Companies Inc.; 329-331
Pregunta 2: opción a
Kaltsas GA, Besser GM, Grossman AB. 2004 The diagnosis and medical management of advanced neuroendocrine tumors. Endocr Rev. Jun; 25(3):458-511.
Pregunta 3:
opción c
Martino E,Bartalena L,Bogazzi F,Braverman LE. 2001 The effects of amiodarone on the thyroid. Endocr Rev. 22(2):240-254.
Pregunta 4:
opción c
Service FJ. 1995 Hypoglycemic disorders. N Engl J Med. 332(17):1144-1852.
Pregunta 5:
opción c
Le Roux CW, Mulla A, Meeran K. 2001 Pituitary carcinoma as a cause of acromegaly. N Engl J Med. Nov 29; 345 (22):1645-1646.
Pregunta 6: opción a y c
Gola M; Doga M; Bonadonna S, Velardo A et al. 2004. Primary Pituitary Lymphoma Endocrinologist. 14(5):288-292
Pregunta 7: opción b
Monnier L, Lapinski H and Collete C 2003 Contributions of fasting and Postprandial Plasma Glucose Increments to the overall Diur nal Hyperglycemia of Type 2 Diabetic Patients: Variations with increasing levels of HbA1c. Diabetes Care 26: 881-885.
Pregunta 8: opción d
Rosen ED and Spiegelman BM 2001 PPARgama: a Nuclear Regulator of Metabolism, Diffrentiation, and Cell Growth. The Journal of Biological Chemistry 276(41) 37731-37734.
Pregunta 9: opción c
Monnier L, Mas E, Ginet C et al 2006. Activation of oxidative stress by acute Glucose Fluctuations compared with sustained chronic Hyperglycemia in patients with Type 2 Diabetes. JAMA 295: 1681-1687.
Pregunta 10: opción b
Akram K, Pedersen-Bjergaard U Carstensen B et al. 2006 Frecuency and risk factors of severe hypoglycaemia in insulin-treated Type 2 diabetes: a crosssectional survey. Diabet Med 23(7): 750-756.
Pregunta 11: opción c
Sigal RJ, Kenny G P, Boulé N G et al. 2007 Effects of aerobic training, resistance training, or both on glycemic control in Type 2 diabetes. Ann Intern Med147: 357-369.
Pregunta 12: opción b
Lautamaki R, Airaksinen KEJ, Seppanen M et al. 2006 Insulin improves myocardial blood flow in patients with type 2 diabetes and coronary artery desease. Diabetes 55: 511-516.